265 related articles for article (PubMed ID: 12569860)
1. U.S. is lone holdout on drug access vote.
AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
[No Abstract] [Full Text] [Related]
2. Drugs for the developing world.
GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
[TBL] [Abstract][Full Text] [Related]
3. International. Rights group: U.S. blocking access to generic AIDS drugs.
AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
[No Abstract] [Full Text] [Related]
4. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
5. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
6. U.N. drug initiative hits the ground.
Cadman J
GMHC Treat Issues; 1998 Jun; 12(6):5-6. PubMed ID: 11365723
[TBL] [Abstract][Full Text] [Related]
7. Access for all?
Lange JM; Thaineua V
Science; 2004 Jun; 304(5679):1875. PubMed ID: 15218109
[No Abstract] [Full Text] [Related]
8. Africa treatment access in the news.
James JS
AIDS Treat News; 2000 May; (343):2-3. PubMed ID: 12170968
[No Abstract] [Full Text] [Related]
9. HIV/AIDS. The great funding surge.
Cohen J
Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
[No Abstract] [Full Text] [Related]
10. International intellectual property, access to health care, and human rights: South Africa v. United States.
Nagan WP
Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137
[No Abstract] [Full Text] [Related]
11. Wealthy nations called on to boost support efforts. Five-year plan estimated to cost $9.2 billion.
Annan K; Piot P; Schwartlander B; Berman D; Davis P; Kaninda AV; Ouma C; Leghentsev K
AIDS Alert; 2001 Aug; 16(8):99-101. PubMed ID: 11547707
[TBL] [Abstract][Full Text] [Related]
12. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
13. European Parliament supports treatment access in developing countries.
James JS
AIDS Treat News; 2001 Mar; (363):4-5. PubMed ID: 11547677
[No Abstract] [Full Text] [Related]
14. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
15. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
16. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report.
Zarocostas J
BMJ; 2011 Mar; 342():d1677. PubMed ID: 21411492
[No Abstract] [Full Text] [Related]
17. U.S. near accord with WTO over generic drug access.
AIDS Policy Law; 2003 Sep; 18(17):1. PubMed ID: 14626953
[No Abstract] [Full Text] [Related]
18. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11702763
[No Abstract] [Full Text] [Related]
19. Uncertain future for early access?
Huff B
GMHC Treat Issues; 2006; 20(1-3):1-3. PubMed ID: 16906670
[No Abstract] [Full Text] [Related]
20. New guidelines increase access to HIV/AIDS medication.
AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
